Clinical Trials Logo
  1. Home
  2. Growth Retardation
  3. NCT03290235

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

Growth Retardation Clinical Trial

Official title:
The Extension Study of Phase IV Clinical Trial of Pegylated Somatropin (PEG Somatropin) to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

Clinical Trial Summary

1. To further evaluate the safety and efficacy of PEG-Somatropin in the treatment of children with growth hormone deficiency for a relatively long period

2. To explore the factors influencing the efficacy of PEG-Somatropin and to establish the height prediction model based on Chinese children with short stature, and to provide the basis and guidance for standard and reasonable long-term clinical application of PEG-Somatropin.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03290235
Study type Interventional
Source GeneScience Pharmaceuticals Co., Ltd.
Contact Xiaohua Feng
Phone 0431-85170552
Email fengxiaohua@gensci-china.com
Status Recruiting
Phase Phase 4
Start date March 1, 2017
Completion date September 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02249754 - Nutrition Education Package for Infants and Young Child Feeding and Health in Rural Tanzania N/A
Completed NCT02438774 - Intervention in Minimizing Aflatoxins and Fumonisins Exposure to Children Through Food and Breastfeeding in Tanzania N/A
Recruiting NCT03053687 - Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy N/A
Completed NCT03217045 - Nutrition Protocol and Premature Infants' Growth
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Completed NCT02716935 - Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants N/A
Completed NCT02403739 - Visual Interpretation of Neonatal Growth Charts N/A
Completed NCT02236468 - Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso N/A
Not yet recruiting NCT01494779 - Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A. Phase 1
Completed NCT05946928 - EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
Completed NCT02259166 - Enhanced Homestead Food Production Plus+ Program in the Lake Zone, Tanzania N/A
Recruiting NCT06071403 - The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
Completed NCT05640596 - Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
Completed NCT04633135 - Research on Emissions, Air Quality, Climate and Cooking Technologies in Northern Ghana N/A
Completed NCT00174278 - Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary Phase 3
Recruiting NCT05518188 - Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) Phase 1/Phase 2
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT00813189 - Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid Phase 3